Zydus Wellness Limited
3,792words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
Rs. 10,000
million
Rs. 15,000 million
₹160
0.7 Million
2.8
million
7.1%
0.7%
2.1%
6.8%
13.4%
14.6%
Speaking time
1
Advertisement
Opening remarks
Major impacts between EBITDA and PBT
• The acquisition funded through a low-cost bridge loan in GBP which is now converted to EUR loan, with interest included in finance costs • Amortization of acquired brands led to higher depreciation and amortization expenses • Exceptional items represent one-time impacts from implementation of the new labour code, acquisition-related costs, and expenses related to the liquidation of Naturell (India) Private Limited, a subsidiary of the Company, on a going-concern basis EPS on Adjusted PAT INR Million Q4 FY26 Q4 FY25 Y-o-Y Growth % FY26 * FY25 ** Y-o-Y Growth % Net Profit after exceptional items 1,620 1,719 -5.8% Amortization of acquired brands Exceptional items *** 467 - 64 - 629.7% N.A Adjusted Net Profit 2,087 1,783 17.0% 1,972 1,174 408 3,554 3,469 -43.2% 64 (59) 3,474 1734.4% N.A 2.3% Number of Shares 31,81,60,720 31,81,60,720 31,81,60,720 31,81,60,720 Adjusted EPS 6.56 5.60 11.17 10.92 * Results for FY26 include the performance of Alidac UK Limited and its subsidiaries for a peri
Advertisement